Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Emerging Markets Series: The Pharmaceutical Market of Poland

Published by: Datamonitor

Published: Jun. 4, 2009 - 264 Pages


Table of Contents


Overview
ABOUT DATAMONITOR HEALTHCARE
About the Strategic Pharmaceutical Analysis Team
Chapter 1 - Executive Summary
Scope
Key findings
Related reports
Table of Contents
Chapter 2 - Demographic trends in Poland
Key findings
Socio and business demographics of Poland
Poland is politically stable
The introduction of Special Economic Zones offer a major incentive for foreign investment
Major incentives to investing in Poland
Major disincentives to investing in Poland
Low corporation income tax is an incentive for foreign investment in Poland
Polish international trade largely confined to the EU
Poland invests little in research and development
Pharmaceutical research and development in Poland is set to increase
Chapter 3 - The healthcare system in Poland
Key findings
The healthcare system in Poland
Healthcare expenditure in Poland
Polish healthcare system is in need of reform
Hospital debt and corruption are crippling the public healthcare system
Polish regulatory landscape
Polish pharmaceutical industry legislation
Pricing and Reimbursement system in Poland lacks consistency
Pricing controls in Poland
Reference pricing in Poland
Hospital tendering procedures
Reimbursement controls in Poland
Positive formulary lists
Agency for Health Technology Assessment (AHTAPol) introduced to curb spending
Pharmacy substitution is a recent change implemented by the Polish government to offer patients greater choice
Chapter 4 - Polish pharmaceutical market
Key findings
Polish pharmaceutical market is growing rapidly
Polish retail market is growing rapidly in value
Cardiovascular, CNS and respiratory pharmaceuticals dominate the Polish retail market
Top brands in the Polish retail market
Poland's hospital pharmaceutical market is growing steadily
Top brands in Poland's hospital market
Oncology drug sales dominate Poland's hospital market
Top pharmaceutical players in Poland are all international companies
Novartis - Poland
GlaxoSmithKline - Poland
Generic players dominate Poland's pharmaceutical market
Polpharma's - Poland's domestic giant
Polish patent and intellectual property law in desperate need of reform
Chapter 5 - Bibliography
APPENDIX
Exchange rates
About Datamonitor
About Datamonitor Healthcare
Datamonitor consulting
Disclaimer
List of Tables
Table 1: Poland: health demographics, 2002-06
Table 2: Poland:, World Health Organization (WHO) core health indicators for healthcare expenditure, 2005
Table 3: Poland: sales for the top ATC groups in the retail pharmaceutical market, 2005-08
Table 4: Poland: top 12 brands in the retail pharmaceutical market, 2005-2008
Table 5: Poland: top 12 brands in the hospital pharmaceutical market, 2005-2008
Table 6: Poland: sales for the top ATC groups in hospital pharmaceutical market, 2005-08
Table 7: Poland: top 10 drug manufacturing companies, 2007-08
Table 8: Poland: top 10 generic pharmaceutical companies, 2008
Table 9: Exchange rates, 2008
List of Figures
Figure 1: Drivers and resistors to investing in Poland
Figure 2: Poland: scientific and innovative indicators, 2009
Figure 3: SWOT analysis of the Polish biotechnology market, 2008
Figure 4: Poland: population estimates, 1980-2050
Figure 5: Poland: value of private healthcare market (PLN billion), 2005-10
Figure 6: Poland: healthcare system network, 2009
Figure 7: Poland: combined total drug sales, 2005-08
Figure 8: Poland: value and volume sales for the retail pharmaceutical market, 2005-08
Figure 9: Poland: top ATC groups in the retail pharmaceutical market, 2005-07
Figure 10: Poland: sales for the top ATC groups in the hospital pharmaceutical market, 2007

Abstract

Introduction

Poland's economy has grown from strength to strength in the past 5 years, and despite the global economic downturn Poland is expected to maintain positive growth through 2010. However, concern exists over intellectual property and inconsistent drug reimbursement. Nevertheless the strong growth of the hospital and retail sectors is encouraging for both foreign and domestic Pharma.

Scope
  • Provides an overview of the evolving demographics of Poland
  • In-depth assessment of its healthcare and regulatory system and the challenges that branded Pharma face
  • Insight into of the competitive dynamics of both the hospital and retail markets
  • Profiles and analysis of key brands and players in the Polish market
Highlights

The Polish government is undertaking structural reforms with the aid of EU funding to improve internal infrastructure in an effort to attract more foreign investment. However, Poland needs to address its regulatory process and get up to speed both implementing and enforcing EU pharmaceutical legislation.

The cardiovascular and central nervous system markets in addition to those for other chronic diseases are forecast to experience significant further growth driven by the growing prevalence of these diseases among the increasingly aging population.

The growth of the Polish oncology hospital market is in part attributed to the significant funding this area has received from the government, with other chronic diseases expected to benefit as the government expands its therapeutic programs into other areas.

Reasons to Purchase
  • Understand the Polish healthcare market and the strategic implications of future reforms and how these will affect your business
  • Identify the opportunities ad barriers for entering the Polish market, plus growth drivers and resistors for established domestic and foreign players
  • Gain insight into the evolving dynamics of the Polish retail and hospital pharmaceutical market


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009